Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
Author - Abby Davey
Nutrien to Divest 50% Equity Stake in Profertil S.A. for US$600...
Nutrien Ltd. has announced an agreement to sell its 50 percent equity stake in Argentina-based...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...
Origin Agritech Begins Large-scale Seed Processing at New...
Origin Agritech Ltd. (NASDAQ: SEED), a leading agricultural technology company, has officially...
Caris Validates MI Cancer Seek® as Reliable Companion Diagnostic...
Caris Life Sciences® (NASDAQ: CAI) has published peer-reviewed clinical validation data in...
Sanofi’s rilzabrutinib earns orphan designation in the EU for...
The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...
Bayer Foundation and United Nations Capital Development Fund...
Bayer Foundation and the United Nations Capital Development Fund (UNCDF) partner to launch the...
Hatteras Venture Partners Raises Over $200 Million in Capital...
Hatteras Venture Partners announced the final closings of Hatteras Venture Partners VII (HVP VII)...